BLOOD-CONCENTRATION AND URINARY-EXCRETION OF CAPTOPRIL (SQ14,225) IN PATIENTS WITH CHRONIC-RENAL-FAILURE

被引：66

作者：

ONOYAMA, K

HIRAKATA, H

ISEKI, K

FUJIMI, S

OMAE, T

KOBAYASHI, M

KAWAHARA, Y

机构：

[1] KYUSHU UNIV, FAC MED, DEPT INTERNAL MED 2, FUKUOKA 812, JAPAN

[2] SHOWA UNIV, FAC MED, DEPT INTERNAL MED 3, TOKYO 142, JAPAN

[3] SANKYO CO LTD, PROD DEV LABS, TOKYO 140, JAPAN

来源：

HYPERTENSION | 1981年 / 3卷 / 04期

关键词：

D O I：

10.1161/01.HYP.3.4.456

中图分类号：

R6 [外科学];

学科分类号：

1002 ; 100210 ;

摘要：

引用

收藏

页码：456 / 459

页数：4

相关论文

共 9 条

[1] CONVERTING ENZYME-INHIBITION WITH AN ORALLY ACTIVE COMPOUND IN HYPERTENSIVE MAN
BRAVO, EL
TARAZI, RC
[J]. HYPERTENSION, 1979, 1 (01) : 39 - 46
[2] ORAL ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR IN LONG-TERM TREATMENT OF HYPERTENSIVE PATIENTS
BRUNNER, HR
GAVRAS, H
WAEBER, B
KERSHAW, GR
TURINI, GA
VUKOVICH, RA
MCKINSTRY, DN
GAVRAS, I
[J]. ANNALS OF INTERNAL MEDICINE, 1979, 90 (01) : 19 - 23
[3] BRUNNER HR, 1978, LANCET, V2, P704
[4] CLINICAL EXPERIENCE WITH BLOCKADE OF RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM BY AN ORAL CONVERTING-ENZYME INHIBITOR (SQ 14,225, CAPTOPRIL) IN HYPERTENSIVE PATIENTS
CASE, DB
ATLAS, SA
LARAGH, JH
SEALEY, JE
SULLIVAN, PA
MCKINSTRY, DN
[J]. PROGRESS IN CARDIOVASCULAR DISEASES, 1978, 21 (03) : 195 - 206
[5] HEMODYNAMICS OF ORALLY-ACTIVE CONVERTING ENZYME-INHIBITOR (SQ 14225) IN HYPERTENSIVE PATIENTS
CODY, RJ
TARAZI, RC
BRAVO, EL
FOUAD, FM
[J]. CLINICAL SCIENCE AND MOLECULAR MEDICINE, 1978, 55 (05): : 453 - 459
[6] ANTIHYPERTENSIVE EFFECT OF ORAL ANGIOTENSIN CONVERTING-ENZYME INHIBITOR SQ 14225 IN MAN
GAVRAS, H
BRUNNER, HR
TURINI, GA
KERSHAW, GR
TIFFT, CP
CUTTELOD, S
GAVRAS, I
VUKOVICH, RA
MCKINSTRY, DN
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1978, 298 (18) : 991 - 995
[7] KAWAHARA Y, 1981, CHEM PHARM BULL, V29, P150
[8] DISPOSITION OF CAPTOPRIL IN NORMAL SUBJECTS
KRIPALANI, KJ
MCKINSTRY, DN
SINGHVI, SM
WILLARD, DA
VUKOVICH, RA
MIGDALOF, BH
[J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1980, 27 (05) : 636 - 641
[9] Metzler C.M., 1974, USERS MANUAL NONLIN